Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-04-26, Stock:JNJ, The news for the past five days is as follows:
2018-04-19: NEWS1: P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI.NEWS2: Healthcare ETFs in Focus After Johnson & Johnson Q1 Earnings.NEWS3: Healthcare ETFs in Focus After Johnson & Johnson Q1 Earnings.NEWS4: Healthcare ETFs in Focus After Johnson & Johnson Q1 Earnings.NEWS5: 3 Drugs That Are Moving the Needle at Johnson & Johnson.NEWS6: 3 Drugs That Are Moving the Needle at Johnson & Johnson.NEWS7: 3 Drugs That Are Moving the Needle at Johnson & Johnson.
2018-04-20: NEWS1: 4 Blue-Chip Stocks to Buy Ahead of Eye-Popping Earnings.NEWS2: J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?.NEWS3: J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?.NEWS4: Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR.NEWS5: Dow 30 Stock Roundup: AmEx, Goldman, IBM, JNJ, P&G, UNH Earnings Impress.NEWS6: Dow 30 Stock Roundup: AmEx, Goldman, IBM, JNJ, P&G, UNH Earnings Impress.NEWS7: J&J, Novartis&apos; Q1 Earnings Impress: Will Others Follow Suit?.NEWS8: AbbVie And Other Great Pharma And Biotech Income Stocks.NEWS9: Dow 30 Stock Roundup: AmEx, Goldman, IBM, JNJ, P&G, UNH Earnings Impress.NEWS10: Johnson & Johnson is betting on vision care and expanding beyond contacts.NEWS11: Johnson & Johnson is betting on vision care and expanding beyond contacts.
2018-04-23: NEWS1: Johnson & Johnson’s Revenues Continued to Rise in 1Q18.NEWS2: Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN.NEWS3: Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN.NEWS4: Johnson & Johnson's Top-Line Growth Isn't What It Seems.NEWS5: Johnson & Johnson's Top-Line Growth Isn't What It Seems.NEWS6: Analysts’ Estimates for Eli Lilly & Co.’s 1Q18 Earnings.NEWS7: Johnson & Johnson&apos;s Top-Line Growth Isn&apos;t What It Seems.NEWS8: Geron Corporation: The Clock Is Ticking.NEWS9: Geron Corporation: The Clock Is Ticking.NEWS10: Geron Corporation: The Clock Is Ticking.NEWS11: Why GlaxoSmithKline’s 1Q18 Revenues Are Expected to Fall.NEWS12: Merck’s Relebactam Met Primary Endpoints in Phase 3 Study.NEWS13: British businesses embrace profits with a purpose.
2018-04-24: NEWS1: Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley.NEWS2: Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley.NEWS3: Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley.NEWS4: Johnson & Johnson to Participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference.NEWS5: Biktarvy Could Be a Major Driver for Gilead Sciences in 2018.NEWS6: NEWS BITES: Police look for motive in deadly Toronto van attack, President George H.W. Bush hospitalized, Prince's family suing hospital that treated him.NEWS7: How Johnson & Johnson’s Pharmaceutical Segment Performed in 1Q18.NEWS8: Analyzing Johnson & Johnson’s Segment-Wise Performance in 1Q18.
2018-04-25: NEWS1: J&J Gets Court to Throw Out $151 Million Artificial Hip Verdict.NEWS2: Buy the Post-Earnings Lull from Johnson & Johnson.NEWS3: Buy the Post-Earnings Lull from Johnson & Johnson.NEWS4: Johnson & Johnson’s Revenue at $20 Billion in 1Q18.NEWS5: Drug Stock Q1 Earnings Due on Apr 26: ABBV, ALXN, BMY & VRTX.NEWS6: Drug Stock Q1 Earnings Due on Apr 26: ABBV, ALXN, BMY & VRTX.NEWS7: Buy the Post-Earnings Lull from Johnson & Johnson.NEWS8: Novartis Launches FocalView to Modernize Clinical Trials.NEWS9: Amgen’s Earnings Grow 12% Year-Over-Year in 1Q18.NEWS10: How Analysts Rate Bristol-Myers Squibb in 1Q18.NEWS11: The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay.NEWS12: The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay.NEWS13: Should OShares FTSE U.S. Quality Dividend ETF (OUSA) Be on Your Investing Radar?.NEWS14: Should OShares FTSE U.S. Quality Dividend ETF (OUSA) Be on Your Investing Radar?.NEWS15: How Did Johnson & Johnson’s Consumer Segment Perform in 1Q18?.NEWS16: The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay.NEWS17: What Do Analysts Predict for Bristol-Myers Squibb in 1Q18?.NEWS18: How Johnson & Johnson’s Medical Devices Segment Performed in 1Q18.

Answer: Rise